Pratik Doshi, MD, MS, and Aakriti Gupta MD, MSc, dive into the latest updates and key takeaways from this month's European Society of Cardiology (ESC) Congress. This expert analysis explores groundbreaking research, clinical advances, and the emerging trends that are poised to influence cardiovascular medicine in the years to come.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on for implementing innovative family communication and cascade testing strategies for familial hypercholesterolemia

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on neutrophil extracellular traps in ST-Segment elevation myocardial infarction.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on the association of anxiety and depression with increased cardiovascular disease risk through accelerated development of risk factors.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on blood pressure and cardiovascular risk in women with breast cancer.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on telemedicine disparities in ambulatory cardiology visits in a large academic health system.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on polypharmacy and guideline-directed medical therapy initiation among adults hospitalized with heart failure.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on outcomes for mechanically ventilated patients with acute myocardial infarction admitted to medical compared to cardiac ICU.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on using blood biomarkers to predict 10-year clinical outcomes in adult patients with Congenital Heart Disease.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper about mortality after multivessel revascularization in patients with diabetes and acute coronary syndromes.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on renin-angiotensin system inhibition in patients with myocardial injury complicating TAVR.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on incremental efficacy for repeat ablation procedures for catheter ablation of AF.

How does Life’s Essential 8 impact cardiovascular disease in high risk populations? Dr. Zhangling Chen discusses her research on how patients with diabetes with a higher Life’s Essential 8 score had a lower risk of developing cardiovascular disease at long term follow-up. Moderated by Amber Tang, MD.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on the association of Cardiac Troponin T with coronary atherosclerosis in asymptomatic primary prevention in people with HIV.

In this JACC: Asia podcast, Roopali Khanna discusses a study on gender disparities in Japanese interventional cardiology, highlighting that female interventionists achieve comparable outcomes to their male counterparts despite performing fewer complex procedures. The research underscores the need for a more equitable professional landscape in the field, noting that women make up only 7-10% of interventionists globally.

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Tom Marwick, MBBS, PhD, MPH discuss the study design, findings and the use of strain surveillance during chemotherapy to improve cardiovascular outcomes.

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Yichao Xiao, MD discuss the study design, findings, future research questions and the potential clinical impact on the management of blood pressure in cancer survivors.

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC, Yen-Wen Liu, MD, PhD, Professor of Medicine, FESC and Yu-Ling Hsu, MD discuss the study design, findings and potential implications for clinical practice and future research questions for the prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.

Tom Marwick, MBBS, PhD, MPH and Sivatharshini Ramalingam, MD discuss discuss the study design and findings, as well as the future use and potential development of cardio-oncology specific risk scores for prediction of heart failure in cancer survivors.

Candice K. Silversides, MD, FACC, Editor-in-Chief of JACC: Advances, and Sabha Bhatti, MD, FACC, discuss Dr. Bhatti's ESC late-breaking study on echocardiographic screening of pregnant women in Pakistan.

Biykem Bozkurt, MD, PhD, FACC, Editor-in-Chief of JACC: Heart Failure, and Akshay S. Desai, MD, MPH, FACC, Deputy Editor of JACC: Heart Failure interview Andrew J. Sauer, MD, on a state-of the-art review examining the current data on mineralocorticoid antagonism in heart failure, published in JACC: Heart Failure and presented at ESC.

In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman highlights key studies from the September 2024 issue, including groundbreaking research on the interplay between cardiometabolic disorders and depression, gender disparities in interventional cardiology, and the efficacy of new treatments for hypertension. The podcast also covers advancements in image-guided angioplasty, emphasizing the importance of integrated care and innovative approaches in cardiovascular medicine.

In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman reviews a pivotal study comparing the angiotensin receptor neprilysin inhibitor sacubitril alisarmin with olmesartan for treating primary hypertension in Chinese patients. The trial found sacubitril alisarmin to be more effective in reducing blood pressure and well-tolerated, suggesting its potential as a new option for hypertension treatment, though further long-term studies are needed.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on optimal hear rate at discharge in hospitalized patients with heart failure and atrial fibrillation.